blood test used News
-
Two Research Studies Bolster Method That C2N’s PrecivityAD Blood Test Uses to Aid Clinicians in Alzheimer’s Disease Diagnoses
Two recent studies demonstrated that the scientific method that serves as the basis for C2N Diagnostics’ PrecivityAD™ blood test scored best compared to others assays in their respective ability to identify amyloid plaque. The C2N Diagnostics PrecivityAD™ blood test that clinicians use to aid in diagnosing Alzheimer’s disease is underpinned by the liquid ...
-
Major Research Findings Highlight Effectiveness of the PrecivityAD™ Blood Test That Clinicians Use to Aid in Alzheimer’s Disease Diagnosis
Four separate research reports presented at premier Alzheimer’s disease and aging conferences add to the increasing set of details about the accuracy and clinical usefulness of the PrecivityAD™ blood test from C2N Diagnostics. The PrecivityAD™ test is a breakthrough blood test intended for use in patients with cognitive impairment. The test helps physicians determine the ...
-
Cleveland Diagnostics Chief Medical Officer, Mark Stovsky, MD, Participates in Panel Discussion on Early Cancer Detection During Cleveland Clinic`s 2019 Medical Innovation Summit
Cleveland Diagnostics, Inc., a clinical-stage company focused on developing next-generation diagnostic tests for the detection of cancers, today announced that its chief medical officer, Mark Stovsky, MD, participated in an Impact Session at the 2019 Medical Innovation Summit organized by Cleveland Clinic. The Medical Innovation Summit, which is celebrating its 17th year, is covering a wide ...
-
New Blood Test Helps Clinicians Pinpoint A Potentially Life-Threatening Sensitization to Insect Stings
ImmunoCAP Specific IgE Stinging Insect Allergen Components have been cleared by the U.S. Food & Drug Administration (FDA) for in vitro diagnostic use. Results from these component tests can act as a diagnostic aid to help specialists and other healthcare providers discriminate between true sensitization and cross reactivity, identify culprit insect(s) in patients with inconclusive patient ...
-
FDA grants Breakthrough Device Designation for Seravue® to support earlier diagnosis of Liver Cancer using a simple blood test
Pennsylvania June 8th, 2020: The FDA has granted Breakthrough Device Designation for Seravue® to support earlier diagnosis of Liver Cancer using a simple blood test. Seravue® is intended for use as an aid in the diagnosis of Hepatocellular Carcinoma (HCC), including early stage HCC, in patients with an elevated risk of developing HCC, in conjunction with ultrasound imaging or alone in ...
-
FDA grants Breakthrough Device Designation for Seravue® to support earlier diagnosis of Liver Cancer using a simple blood test
Pennsylvania June 8th, 2020: The FDA has granted Breakthrough Device Designation for Seravue® to support earlier diagnosis of Liver Cancer using a simple blood test. Seravue® is intended for use as an aid in the diagnosis of Hepatocellular Carcinoma (HCC), including early stage HCC, in patients with an elevated risk of developing HCC, in conjunction with ultrasound imaging or alone in ...
-
FDA Clears First Blood Test for Identifying a Novel Allergic Sensitization to Red Meat
ImmunoCAP Specific IgE alpha-Gal Allergen Component test has been cleared by the U.S. Food & Drug Administration (FDA) for in vitro diagnostic use. Test results can aid specialists and other healthcare providers as they diagnose a patient's sensitization to the alpha-Gal carbohydrate found in mammalian (red) meat and assess his or her risk for an anaphylactic reaction. According to the ...
-
Alzheimer’s Breakthrough: C2N First to Offer a Widely Accessible Blood Test
Who Want Earlier Answers Patients, advocates, and physicians who have long awaited an easy to administer blood test that can help them better understand Alzheimer’s disease now have a health care innovation which they can rely upon. A breakthrough in Alzheimer’s disease has arrived with the introduction of C2N Diagnostics’ PrecivityAD™ blood test into the clinic. ...
-
New Blood Tests Help Assess Asthma Risk and Decide Pet Selection
AACC 2019 – New blood tests may help healthcare providers identify if patients are sensitized to up to 11 different molecular allergen component proteins found in dogs, cats, or horses. The assays analyze sensitivity to specific proteins found in the skin, fur and saliva of these animals. ImmunoCAP Allergen Components test for Furry Animal have been cleared by the U.S. Food & Drug ...
-
Guardant Health Announces Shield™ Blood Test Available in US to Detect Early Signs of Colorectal Cancer in Average-Risk Adults
Highly sensitive Shield test offers convenient screening method that can be completed with simple blood draw, helping overcome barriers to compliance Test demonstrated sensitivity of 91% in colorectal cancer and 20% in advanced adenoma detection with specificity of 92% in validation studies PALO ALTO, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology ...
-
PixCell Medical Signs Point of Care Diagnostics as Sole Distributor of HemoScreen™ in Australasia Region
PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, announced today that it has signed a distribution agreement with Point of Care Diagnostics Aus. Pty Ltd (POCD), supplier and distributor of point-of-care testing solutions to Australasia, making POCD the sole regional distributor of the HemoScreen™, a small-sized, simple-to-operate diagnostic platform designed ...
-
Sight Diagnostics raises $71 million amidst Covid-19 demand for blood count devices
Israeli blood testing startup S.D. Sight Diagnostics Ltd. has raised $71 million from international venture capital funds and U.S. corporations, Clal Biotechnology Industries Ltd. revealed in a report sent to the Tel Aviv Stock Exchange last week. Sight Diagnostics has yet to announce the details of the new funding round, but Clal Biotechnology Industries stated in its report that following the ...
-
GRAIL Statement on President Biden’s Bold Initiative to Reignite the Cancer Moonshot
“We applaud President Biden for reigniting the Cancer Moonshot and highlighting the critical role of early detection in achieving the ambitious, but attainable, goal of reducing the cancer death rate by at least 50 percent in the next 25 years. Improving quality of life for patients and survivors, while addressing inequities in access to cancer screening, diagnostics and treatment is a ...
By Grail, Inc.
-
POGO Automatic One-Step™ Blood Glucose Monitor Now Available for People with Diabetes in the United States
Intuity Medical, Inc., a commercial-stage medical technology and digital health company focused on making life with diabetes easier, announced today the availability of the POGO Automatic Blood Glucose Monitoring System in the U.S. The product is the first and only FDA-cleared blood glucose monitor whose 10-test cartridge technology makes a glucose test possible with only the press of a button ...
-
Bluejay Completes Planned Clinical Studies for Symphony IL-6 Test
Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”, “the Company”), a medical diagnostics company focused on developing cost-effective, rapid, near-patient products for triage and monitoring of disease progression, today announced completion of its previously planned clinical studies for the Symphony IL-6 Test (the “Test”). Results of these studies will be ...
-
Peer-Reviewed Journal Publishes Analytical Validation Results for the PrecivityAD Blood Test, Which Can Help Clinicians Detect Alzheimer’s Disease
C2N Diagnostics, which offers the PrecivityAD™ blood test that can help detect if certain markers for Alzheimer’s disease are in the brain, now has its analytical validation results available for review. The study appears in Clinica Chimica Acta, the official peer-reviewed journal of the International Federation of Clinical Chemistry and Laboratory Medicine. The article is titled ...
-
Understanding the different types of COVID-19 Testing
For COVID-19 testing, there are two predominant tests on the market: viral tests and serum antibody tests. Let’s take a look at the main differences between these two types of tests, like what they look for, when each is the most effective, and the logistics of providing each type. 1. Viral Tests Viral, or PCR, tests determine if an individual currently has COVID-19 by testing for the ...
By MiraDx
-
Making a Prostate Exam as Comfortable as Possible: Caring For Your Patients
In honor of November being prostate cancer awareness month, today’s post is dedicated to discussing prostate exams and how medical professionals can help make them as comfortable as possible. This is in an effort to help promote as many men as possible to have their prostates checked to reduce the incidence of prostate cancer or to identify it in the earlier stages. Before we dive right ...
-
Bluejay Diagnostics Appoints Edwin Rule as Vice President, Regulatory, Quality and Compliance
Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay”, “the Company”) a late-stage, pre-revenue diagnostics company focused on developing cost-effective, rapid, near-patient products for triage and monitoring of disease progression, today announced that Edwin “Ed” E. Rule, has joined the Company as Vice President Regulatory, Quality and Compliance. He will report ...
-
Why we Started (TBT): HIV Testing
Why HIV Testing is Important HIV Testing is critical to reducing its spread. The CDC recommends that all people ages 13-64 get tested at least once, and individuals deemed high risk should be tested more frequently. A positive test allows individuals to then seek treatment (there are several forms of effective treatment currently available) and prevent transmission to others. How HIV Testing ...
By Fluxergy
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you